We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.46B
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
+$1.23B
Cap. Flow
+$904M
Cap. Flow %
20.28%
Top 10 Hldgs %
37.6%
Holding
139
New
33
Increased
39
Reduced
42
Closed
23

Top Buys

Rank Stock Value
1
FER icon
Ferrovial N.V. Ordinary Shares
FER
+$167M
2
EXC icon
Exelon
EXC
+$156M
3
AEE icon
Ameren
AEE
+$137M
4
SRE icon
Sempra
SRE
+$136M
5
CCI icon
Crown Castle
CCI
+$128M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$108M
2
MSFT icon
Microsoft
MSFT
+$91.6M
3
B
Barrick Mining
B
+$63.5M
4
JCI icon
Johnson Controls International
JCI
+$58.9M
5
COF icon
Capital One
COF
+$53.6M

Sector Composition

Rank Sector Weight
1 Utilities 29.08%
2 Healthcare 12.43%
3 Technology 11.96%
4 Financials 8.08%
5 Materials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORIC icon
101
Oric Pharmaceuticals
ORIC
$1.41B
$34.8K ﹤0.01%
2,901
-2,293
-44% -$24.1K
NUVL
102
DELISTED
Nuvalent
NUVL
$33.8K ﹤0.01%
391
-88
-18% -$6.96K
SYK icon
103
Stryker
SYK
$133B
$33.6K ﹤0.01%
+91
New +$35.2K
APGE icon
104
Apogee Therapeutics
APGE
$10.2B
$33.5K ﹤0.01%
843
+246
+41% +$9.39K
JANX icon
105
Janux Therapeutics
JANX
$1B
$32.9K ﹤0.01%
1,344
+296
+28% +$7.21K
WAY
106
Waystar Holding Corp
WAY
$4.74B
$31.2K ﹤0.01%
823
+449
+120% +$16.6K
FOLD
107
DELISTED
Amicus Therapeutics
FOLD
$30.9K ﹤0.01%
+3,926
New +$27.9K
DHR icon
108
Danaher
DHR
$147B
$27.2K ﹤0.01%
+137
New +$27.3K
WAT icon
109
Waters Corp
WAT
$40.4B
$26.4K ﹤0.01%
+88
New +$26.6K
SGMT icon
110
Sagimet Biosciences
SGMT
$591M
$21.8K ﹤0.01%
3,176
-2,236
-41% -$18.1K
IDYA icon
111
IDEAYA Biosciences
IDYA
$3.54B
$21K ﹤0.01%
+770
New +$18.6K
HUMA icon
112
Humacyte
HUMA
$201M
$14.1K ﹤0.01%
8,125
+951
+13% +$1.86K
ARRY icon
113
Array Technologies
ARRY
$819M
$14K ﹤0.01%
1,715
+457
+36% +$3.46K
DAWN
114
DELISTED
Day One Biopharmaceuticals
DAWN
$12.2K ﹤0.01%
1,731
-1,275
-42% -$8.77K
SQM icon
115
Sociedad Química y Minera de Chile
SQM
$20.8B
$7.82K ﹤0.01%
182
-49
-21% -$2.04K
SHLS icon
116
Shoals Technologies Group
SHLS
$1.44B
$7.25K ﹤0.01%
+978
New +$6.02K
BAH icon
117
Booz Allen Hamilton
BAH
$9.37B
– –
-16,409
Closed -$1.71M
CENX icon
118
Century Aluminum
CENX
$5.14B
– –
-153,131
Closed -$2.76M
CORZ icon
119
Core Scientific
CORZ
$6.25B
– –
-1,391
Closed -$23.7K
CRTO icon
120
Criteo S.A. Ordinary Shares
CRTO
$902M
– –
-608,302
Closed -$14.6M
CX icon
121
Cemex
CX
$16.3B
– –
-6,018,838
Closed -$41.7M
GBTG icon
122
American Express Global Business Travel
GBTG
$4.94B
– –
-32,085
Closed -$202K
GDX icon
123
VanEck Gold Miners ETF
GDX
$27.6B
– –
-64,741
Closed -$3.37M
GDXJ icon
124
VanEck Junior Gold Miners ETF
GDXJ
$8.54B
– –
-58,457
Closed -$3.95M
LUMN icon
125
Lumen
LUMN
$6.85B
– –
-11,386
Closed -$49.9K
2 3 4
5
6

Similar funds

DWA
Douglass Winthrop Advisors New York $5.46B AUM 11.49% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
LP
Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WL
WIT LLC District Of Columbia, District of Columbia $5.3B AUM 20.46% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Antipodes Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Antipodes Partners held 139 positions worth $4.46B, up 38% from $3.22B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Antipodes Partners deployed $904M of net new capital in Q3 2025, opening 33 new positions and adding to 39 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 3,097,701 shares worth $176M.

By sector, the portfolio is most concentrated in Utilities at 29% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $108M trimmed.

  • Antipodes Partners's largest Q3 2025 buy was Ferrovial N.V. Ordinary Shares: 3,097,701 shares worth $176M.
  • Antipodes Partners added most to Exelon in Q3 2025, an estimated $156M increase.
  • Antipodes Partners's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $108M.
  • Antipodes Partners fully exited Micron Technology in Q3 2025, selling an estimated $49.7M.
  • Antipodes Partners's ten largest holdings make up 38% of its $4.46B portfolio in Q3 2025.
  • Antipodes Partners opened 33 new positions and closed 23 in Q3 2025.
  • Antipodes Partners's portfolio value rose 38% quarter-over-quarter to $4.46B.

Based on Antipodes Partners's 13F filing for Q3 2025, filed 10 Nov 2025.